Lobbying Relationship

Client

Astellas Pharma US, Inc.

More records

Lobbying firm

PORTERFIELD, FETTIG & SEARS, LLC

More records

  • Issues related to P.L. 96-517, the Bayh-Dole Act; general issues related to drug research and innovation.

Duration: to

General Issues: Health Issues, Government Issues, Trade (Domestic & Foreign), Telecommunications, Communications/Broadcasting/Radio/TV, Pharmacy, Medicare/Medicaid

Spending: about $1,680,000 (But it's complicated. Here's why.)

Agencies lobbied since 2014: U.S. Senate, House of Representatives, Natl Institutes of Health (NIH)

Related Foreign Entities: Astellas Pharma, Inc. (Tokyo, JPN); contribution to lobbying: $0; ownership 100%

Bills mentioned

S.1519: National Defense Authorization Act for Fiscal Year 2018

Sponsor: John McCain (R-Ariz.)

H.R.2810: National Defense Authorization Act for Fiscal Year 2018

Sponsor: William M. Thornberry (R-Texas)

H.R.2430: FDA Reauthorization Act of 2017

Sponsor: Greg Walden (R-Ore.)

H.R.1178: Ensuring Equal Access to Treatments Act of 2015

Sponsor: Tom Reed (R-N.Y.)

S.1466: Ensuring Equal Access to Treatments Act of 2015

Sponsor: Mark Steven Kirk (R-Ill.)

H.R.2739: Cancer Drug Coverage Parity Act of 2015

Sponsor: Leonard Lance (R-N.J.)

H.R.4923: American Manufacturing Competitiveness Act of 2016

Sponsor: Kevin Brady (R-Texas)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.4857: Ensuring Equal Access to Treatments Act of 2014

Sponsor: Tom Reed (R-N.Y.)

S.2980: Ensuring Equal Access to Treatments Act of 2014

Sponsor: Robert Menendez (D-N.J.)

S.2482: Foreign Agents Registration Amendments Act of 2018

Sponsor: Dianne Feinstein (D-Calif.)

S.2039: Disclosing Foreign Influence Act

Sponsor: Charles E. Grassley (R-Iowa)

H.R.4170: Disclosing Foreign Influence Act

Sponsor: Mike Johnson (R-La.)

H.R.6505: Medicare Negotiation and Competitive Licensing Act of 2018

Sponsor: Lloyd Doggett (D-Texas)

H.R.6294: REVAMP Act

Sponsor: John Shimkus (R-Ill.)

H.R.6157: Department of Defense and Labor, Health and Human Services, and...

Sponsor: Kay Granger (R-Texas)

H.R.1046: Medicare Negotiation and Competitive Licensing Act of 2019

Sponsor: Lloyd Doggett (D-Texas)

H.R.1: For the People Act of 2019

Sponsor: John Sarbanes (D-Md.)

S.1416: Affordable Prescriptions for Patients Act of 2019

Sponsor: John Cornyn (R-Texas)

S.2387: We PAID Act

Sponsor: Chris Van Hollen (D-Md.)

H.R.3877: Bipartisan Budget Act of 2019

Sponsor: John Yarmuth (D-Ky.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

S.2543: Prescription Drug Pricing Reduction Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

H.R.1425: Patient Protection and Affordable Care Enhancement Act

Sponsor: Angie Craig (D-Minn.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.3684: Infrastructure Investment and Jobs Act

Sponsor: Peter A. DeFazio (D-Ore.)

H.R.5376: Inflation Reduction Act of 2022

Sponsor: John Yarmuth (D-Ky.)

H.R.5237: Reduced Costs and Continued Cures Act of 2021

Sponsor: Scott Peters (D-Calif.)

H.R.7667: Food and Drug Amendments of 2022

Sponsor: Anna G. Eshoo (D-Calif.)

S.4348: FDASLA Act of 2022

Sponsor: Patty Murray (D-Wash.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Jeremy Rabinovitz Chief of Staff; Rep. Lois Capps Chief of Staff; Rep. Walter Capps Chief of Staff; Rep. Carolyn Maloney Chief of Staff, Leg Assistant; Rep. Stephen Solarz Chief of Staff; Leg Assistant, Rep. Stephen Solarz
Dwight Fettig Staff Director; Senate Banking Committee, Chairman Johnson Legislative Director; Rep. Tim Johnson

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration
Q4 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page